Jyh‐Chin Yang

2.3k total citations
93 papers, 1.8k citations indexed

About

Jyh‐Chin Yang is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Gastroenterology. According to data from OpenAlex, Jyh‐Chin Yang has authored 93 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Surgery, 22 papers in Pulmonary and Respiratory Medicine and 20 papers in Gastroenterology. Recurrent topics in Jyh‐Chin Yang's work include Helicobacter pylori-related gastroenterology studies (58 papers), Gastroesophageal reflux and treatments (18 papers) and Veterinary medicine and infectious diseases (17 papers). Jyh‐Chin Yang is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (58 papers), Gastroesophageal reflux and treatments (18 papers) and Veterinary medicine and infectious diseases (17 papers). Jyh‐Chin Yang collaborates with scholars based in Taiwan, United States and China. Jyh‐Chin Yang's co-authors include Chun‐Jung Lin, Jann‐Tay Wang, Yen‐Hsuan Ni, Mei‐Hwei Chang, Yow‐Shieng Uang, Chiang‐Ting Chien, Chia‐Hao Chen, Chia‐Tung Shun, Jaw‐Town Lin and Shiu-Feng Huang and has published in prestigious journals such as The Journal of Immunology, Gastroenterology and PLoS ONE.

In The Last Decade

Jyh‐Chin Yang

87 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jyh‐Chin Yang Taiwan 24 1.3k 445 429 318 283 93 1.8k
Masumi Okuda Japan 23 1.2k 1.0× 334 0.8× 453 1.1× 249 0.8× 234 0.8× 67 1.6k
Anthony O’Connor Ireland 25 1.1k 0.9× 385 0.9× 476 1.1× 307 1.0× 244 0.9× 66 1.7k
Ratha‐Korn Vilaichone Thailand 24 1.6k 1.3× 703 1.6× 493 1.1× 341 1.1× 484 1.7× 130 2.2k
Floriana Giorgio Italy 24 1.3k 1.1× 405 0.9× 516 1.2× 555 1.7× 150 0.5× 61 1.8k
Yong Xie China 29 1.6k 1.3× 685 1.5× 569 1.3× 499 1.6× 494 1.7× 108 2.6k
Sadegh Massarrat Iran 22 994 0.8× 366 0.8× 435 1.0× 223 0.7× 185 0.7× 83 1.3k
C O'Morain Ireland 19 2.3k 1.8× 735 1.7× 1.1k 2.7× 526 1.7× 292 1.0× 46 2.7k
Katsuhiro Mabe Japan 23 1.4k 1.1× 1.0k 2.3× 541 1.3× 168 0.5× 123 0.4× 80 2.0k
Elżbieta Karczewska Poland 21 693 0.6× 267 0.6× 157 0.4× 155 0.5× 173 0.6× 64 1.1k
A. L. Blum Switzerland 18 1.2k 0.9× 232 0.5× 779 1.8× 201 0.6× 252 0.9× 47 1.6k

Countries citing papers authored by Jyh‐Chin Yang

Since Specialization
Citations

This map shows the geographic impact of Jyh‐Chin Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jyh‐Chin Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jyh‐Chin Yang more than expected).

Fields of papers citing papers by Jyh‐Chin Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jyh‐Chin Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jyh‐Chin Yang. The network helps show where Jyh‐Chin Yang may publish in the future.

Co-authorship network of co-authors of Jyh‐Chin Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Jyh‐Chin Yang. A scholar is included among the top collaborators of Jyh‐Chin Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jyh‐Chin Yang. Jyh‐Chin Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hsu, Ping‐I, Chien‐Lin Chen, Kuan-Yang Chen, et al.. (2025). Vonoprazan High-Dose Dual, Vonoprazan Triple, and Rabeprazole Reverse Hybrid Therapies for First-Line Treatment of Helicobacter pylori Infection: A Multicenter Randomized Trial. The American Journal of Gastroenterology. 2 indexed citations
2.
3.
Reed, Shelby D., Arijita Deb, Jared Silver, et al.. (2025). Patient preferences for treatment of chronic rhinosinusitis with nasal polyps.. PubMed. 63(2). 245–247. 1 indexed citations
4.
5.
Chen, Chien‐Lin, Deng‐Chyang Wu, Wei‐Yi Lei, et al.. (2023). Independent Risk Factors Predicting Eradication Failure of Hybrid Therapy for the First-Line Treatment of Helicobacter pylori Infection. Microorganisms. 12(1). 6–6. 8 indexed citations
6.
Hsu, Ping‐I, Kuan-Yang Chen, Wei‐Chen Tai, et al.. (2023). Hybrid, High-Dose Dual and Bismuth Quadruple Therapies for First-Line Treatment of Helicobacter pylori Infection in Taiwan: A Multicenter, Open-Label, Randomized Trial. The American Journal of Gastroenterology. 118(7). 1184–1195. 12 indexed citations
7.
Tu, Yu‐Kang, et al.. (2020). Efficacy of second-line regimens for Helicobacter pylori eradication treatment: a systemic review and network meta-analysis. BMJ Open Gastroenterology. 7(1). e000472–e000472. 13 indexed citations
8.
Tan, Bei, Jyh‐Chin Yang, Carol Young, et al.. (2017). Helicobacter pylori Antimicrobial Susceptibility Testing-Guided Salvage Therapy in the USA: A Real Life Experience. Digestive Diseases and Sciences. 63(2). 437–445. 20 indexed citations
9.
Yang, Jyh‐Chin, Chun‐Jung Lin, John Y. Kao, et al.. (2014). High-dose Dual Therapy Is Superior to Standard First-line or Rescue Therapy for Helicobacter pylori Infection. Clinical Gastroenterology and Hepatology. 13(5). 895–905.e5. 159 indexed citations
10.
11.
Yang, Jyh‐Chin, Jin‐Ming Wu, I‐Rue Lai, et al.. (2013). Combined cholecystectomy in gastric cancer surgery. International Journal of Surgery. 11(4). 305–308. 17 indexed citations
12.
Chiu, Hung‐Chuan, Tzu‐Lung Lin, Jyh‐Chin Yang, & Jann‐Tay Wang. (2009). Synergistic effect of imp/ostA and msbA in hydrophobic drug resistance of Helicobacter pylori. BMC Microbiology. 9(1). 136–136. 14 indexed citations
13.
Yang, Jyh‐Chin, et al.. (2008). Effective Prevention and Treatment of Helicobacter pylori Infection Using a Combination of Catechins and Sialic Acid in AGS Cells and BALB/c Mice. Journal of Nutrition. 138(11). 2084–2090. 47 indexed citations
14.
Yang, Jyh‐Chin, et al.. (2005). Decreased Concentration of Plasma Brain-Derived Neurotrophic Factor in Suicide Attempters.. 12(2). 189–195. 1 indexed citations
15.
Yang, Jyh‐Chin, et al.. (2004). Helicobacter pylori enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in human gastric epithelial cells. 世界胃肠病学杂志：英文版（电子版）. 10(16). 2334–2339. 4 indexed citations
16.
Yang, Jyh‐Chin, et al.. (2004). Pre-treatment urea breath test results predict the efficacy of Helicobacter pylori eradication therapy in patients with active duodenal ulcers. 世界胃肠病学杂志：英文版（电子版）. 10(7). 991–994. 3 indexed citations
17.
Lai, Yo‐Ping, Jyh‐Chin Yang, T. M. Lin, Jann‐Tay Wang, & Jaw‐Town Lin. (2003). CagA Tyrosine Phosphorylation in Gastric Epithelial Cells Caused by Helicobacter pylori in Patients with Gastric Adenocarcinoma. Helicobacter. 8(3). 235–243. 23 indexed citations
18.
Lee, Tzong‐Hsi, et al.. (2001). Effect of mouth washing on the [13C]‐urea breath test. Journal of Gastroenterology and Hepatology. 16(3). 261–263. 7 indexed citations
19.
Lin, J.-T., et al.. (1994). Prospective, randomized study of H2-blocker and triple therapy for duodenal ulcer treatment and the eradication of Helicobacter pylori.. PubMed. 93(5). 368–73. 10 indexed citations
20.
Yang, Jyh‐Chin, et al.. (1977). [Pharmacological studies on Chinese herbs. (5) Antipyretic effects of 12 Chinese herbs].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 76(4). 338–43. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masumi Okuda Breakdown of academic impact, for papers by Anthony O’Connor Breakdown of academic impact, for papers by Ratha‐Korn Vilaichone Breakdown of academic impact, for papers by Floriana Giorgio Breakdown of academic impact, for papers by Yong Xie Breakdown of academic impact, for papers by Sadegh Massarrat Breakdown of academic impact, for papers by C O'Morain Breakdown of academic impact, for papers by Katsuhiro Mabe Breakdown of academic impact, for papers by Elżbieta Karczewska Breakdown of academic impact, for papers by A. L. Blum
Rankless by CCL
2026